Search

everythinglearnresearchcommunity

for

Search:↓

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

A man with a type of skin lymphoma had unusual yellowish skin growths despite normal blood lipid levels, and treatment reduced some symptoms but not the growths.

The patient's long-term hair loss was caused by leukemia treatments and low estrogen levels, worsened by her genetic tendency for hair loss.

Early baldness increases prostate cancer risk, radiotherapy and surgery have similar second cancer rates, and ALA may reduce prostate cancer risk.

Radiotherapy affects mitochondrial-related genes in metastatic breast cancer cells.

Curcumin may improve cancer radiotherapy by making cancer cells more sensitive to radiation and protecting normal cells.

A man experienced hair loss from radiotherapy, which can be temporary or permanent depending on radiation dose, with potential treatments available.

The session covered updates on skin treatments, including radiotherapy, imiquimod, acitretin, JAK inhibitors, and strategies for managing rosacea and preventing surgical infections.

Nasopharyngeal carcinoma is a common cancer in Indonesia, with risk factors including genetics, diet, and Epstein-Barr virus, and is treated with advanced radiotherapy.

Vijaya successfully fought stage 2A breast cancer with surgery, chemotherapy, radiotherapy, and hormone therapy, while advocating for support groups.

HPV infection is linked to better survival in advanced anal cancer, higher radiation doses improve survival, especially in HPV-negative patients, and prostaglandin E₂ pretreatment can protect mouse hair follicles from radiation damage.

Mitochondria may influence how cells respond to radiation, affecting nearby non-irradiated cells.

Low-dose radiation therapy may improve brain function in some Alzheimer's patients and is generally well-tolerated.

Combining hyperthermia with natural compounds and conventional treatments improves cancer therapy effectiveness and reduces side effects.

Activating certain hair follicle cells could prevent hair loss from cancer treatments.

Different prostate cancer treatments have similar risks of secondary cancers and related mortality when considering patient age and smoking history.

Radiation damages salivary glands by harming blood vessels, but antioxidants might help protect them.

Certain cells outside the hair follicle's bulge area can quickly regenerate damaged hair follicles, potentially helping to reduce hair loss from cancer treatments.

Cell extracts may effectively and safely repair radiation-damaged salivary glands.

Chemotherapy caused the patient's hair to have alternating thick and thin segments.

Hormone therapy might be a proactive alternative to watchful waiting for early-stage prostate cancer, potentially improving survival without aggressive treatment downsides.

Temozolomide improves survival in grade III glioma patients without harming quality of life.

Hydrogels show promise in preventing and treating skin damage from radiation therapy.

We lack effective keloid treatments because their causes are not well understood.

Potassium channel activators like nicotinamide and minoxidil might help treat solid tumors.

Hair transplants can risk reactivating lichen planopilaris, a scarring hair loss condition.

Advanced hydrogels can autonomously deliver drugs to treat radiation skin injuries, but challenges remain for clinical use.

Nanocarriers can improve skin treatments after cancer therapy by enhancing antioxidant delivery and effectiveness.

Sonidegib effectively treated basal cell carcinoma in a patient with lupus without worsening lupus symptoms.